SCHEMBL6936199

SCHEMBL6936199

NC(=O)c1cn([C@@H](CO)CCn2ccc3ccc(NC(=O)NCCc4ccccc4)cc32)cn1

nearest known ligand 0.85

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ADA P00813 20/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6940323 0.92 ADA (1.00) ADA
SCHEMBL6936397 0.89 ADA (1.00) ADA
SCHEMBL6940576 0.89 ADA (0.68) ADA
SCHEMBL6939245 0.88 ADA (0.95) ADA
SCHEMBL6936203 0.88 ADA (0.66) ADA
SCHEMBL6936078 0.88 ADA (0.79) ADA
SCHEMBL6942214 0.87 ADA (1.00) ADA
SCHEMBL6939033 0.86 ADA (1.00) ADA
SCHEMBL6942221 0.86 ADA (0.81) ADA
SCHEMBL6943108 0.84 ADA (1.00) ADA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596738-B1 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-22 US disclosed
EP-1161429-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-12-12 EP disclosed
WO-2000055155-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-09-21 WO disclosed